Study for apoptosis inhibitor of macrophage (Free AIM) for the prediction of hepatocellular carcinoma.

Study for apoptosis inhibitor of macrophage (Free AIM) for the prediction of hepatocellular carcinoma. - Diagnostic performance of Free AIM for HCC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030348

Enrollment

1600

Registered

2017-12-11

Start date

2017-12-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with chronic hepatitis/cirrhosis/hepatocellular carcinoma who have given written informed consent for preservation of serum sample for research purpose

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of plasma concentration of Free AIM for hepatocellular carcinoma	—

Countries

Japan

Contacts

Public ContactSato Masaya

The University of Tokyo Department of Clinical Laboratory Medicine

masayasato0407@gmail.com0338155411

Outcome results